96 related articles for article (PubMed ID: 17933458)
1. A possible anti-proliferative and anti-metastatic effect of irradiated riboflavin in solid tumours.
de Souza Queiroz KC; Zambuzzi WF; Santos de Souza AC; da Silva RA; Machado D; Justo GZ; Carvalho HF; Peppelenbosch MP; Ferreira CV
Cancer Lett; 2007 Dec; 258(1):126-34. PubMed ID: 17933458
[TBL] [Abstract][Full Text] [Related]
2. Ferruginol suppresses survival signaling pathways in androgen-independent human prostate cancer cells.
Bispo de Jesus M; Zambuzzi WF; Ruela de Sousa RR; Areche C; Santos de Souza AC; Aoyama H; Schmeda-Hirschmann G; Rodríguez JA; Monteiro de Souza Brito AR; Peppelenbosch MP; den Hertog J; de Paula E; Ferreira CV
Biochimie; 2008 Jun; 90(6):843-54. PubMed ID: 18294971
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line.
Chang KL; Cheng HL; Huang LW; Hsieh BS; Hu YC; Chih TT; Shyu HW; Su SJ
Cancer Lett; 2009 Apr; 276(1):14-20. PubMed ID: 19091461
[TBL] [Abstract][Full Text] [Related]
4. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro.
Wollensak G; Spoerl E; Reber F; Seiler T
Eye (Lond); 2004 Jul; 18(7):718-22. PubMed ID: 14739922
[TBL] [Abstract][Full Text] [Related]
5. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
6. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
Minelli A; Bellezza I; Tucci A; Rambotti MG; Conte C; Culig Z
Prostate; 2009 Apr; 69(5):538-47. PubMed ID: 19107848
[TBL] [Abstract][Full Text] [Related]
7. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
[TBL] [Abstract][Full Text] [Related]
10. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
11. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
14. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum.
Mahajna J; Dotan N; Zaidman BZ; Petrova RD; Wasser SP
Nutr Cancer; 2009; 61(1):16-26. PubMed ID: 19116872
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis of DU145 human prostate cancer cells induced by dehydrocostus lactone isolated from the root of Saussurea lappa.
Kim EJ; Lim SS; Park SY; Shin HK; Kim JS; Park JH
Food Chem Toxicol; 2008 Dec; 46(12):3651-8. PubMed ID: 18848968
[TBL] [Abstract][Full Text] [Related]
17. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.
Huang YW; Wang LS; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2009 Jun; 29(6):2179-88. PubMed ID: 19528479
[TBL] [Abstract][Full Text] [Related]
18. Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells.
Thati B; Noble A; Creaven BS; Walsh M; McCann M; Devereux M; Kavanagh K; Egan DA
Eur J Pharmacol; 2009 Jan; 602(2-3):203-14. PubMed ID: 19041861
[TBL] [Abstract][Full Text] [Related]
19. Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancer.
Shaw G; Oliver RT
Surg Oncol; 2009 Sep; 18(3):275-82. PubMed ID: 19269165
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by thiosulfinates in primary human prostate cancer cells.
Kim SY; Park KW; Kim JY; Shon MY; Yee ST; Kim KH; Rhim JS; Yamada K; Seo KI
Int J Oncol; 2008 Apr; 32(4):869-75. PubMed ID: 18360714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
